Publications by authors named "David Cullins"

Claim this Profile
S
Single-cell transcriptomics reveals heterocellular g-globin gene expression in Agdb-thalassemia.
Phillip A Doerfler, Yichao Li, Yu Yao, Ruopeng Feng, Thiyagaraj Mayuranathan, David Cullins

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL.
Aimee C Talleur, Amr Qudeimat, Jean-Yves Métais, Deanna Langfitt, Ewelina Mamcarz, David Cullins

Blood Adv· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trial.
Rosa Nguyen, Natasha Sahr, April Sykes, Mary Beth McCarville, Sara M Federico, David Cullins

J Immunother Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia.
Rosa Nguyen, Huiyun Wu, Stanley Pounds, Hiroto Inaba, Raul C Ribeiro, David Cullins

J Immunother Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the Syk-Dependent T Cell Signaling Response to an Altered Peptide.
Jeoung-Eun Park, Jeffrey A Rotondo, David L Cullins, David D Brand, Ae-Kyung Yi

J Immunol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide ligand structure and I-Aq binding avidity influence T cell signaling pathway utilization.
Linda K Myers, David L Cullins, Jeoung-Eun Park, Ae-Kyung Yi, David D Brand

Clin Immunol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of T cell phenotype and function in a double transgenic (collagen-specific TCR/HLA-DR1) humanized model of arthritis.
Bo Tang, Seunghyun Kim, Sarah Hammond, David L Cullins, David D Brand

Arthritis Res Ther· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular basis for T cell response induced by altered peptide ligand of type II collagen.
Jeoung-Eun Park, David Cullins, Lillian Zalduondo, Stacey L Barnett, Ae-Kyung Yi

J Biol Chem· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of inhibitory T cells induced by an analog of type II collagen in an HLA-DR1 humanized mouse model of autoimmune arthritis.
Masaru Kimata, David L Cullins, Monica L Brown, David D Brand, Edward F Rosloniec

Arthritis Res Ther· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cells stimulated with an analog peptide of type II collagen require the Fc receptor γ-chain to secrete interleukin-4 and suppress autoimmune arthritis in mice.
Linda K Myers, David L Cullins, David D Brand, Sandra Kleinau, John M Stuart

Arthritis Rheum· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of collagen-induced arthritis by adenovirus-mediated intra-articular expression of modified collagen type II.
Bo Tang, David L Cullins, Jing Zhou, Janice A Zawaski, Hyelee Park

Arthritis Res Ther· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell receptor signaling induced by an analog peptide of type II collagen requires activation of Syk.
Bo Tang, Jing Zhou, Jeoung-Eun Park, David Cullins, Ae-Kyung Yi

Clin Immunol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis